Showing posts with label better outcomes in erythropoietin-refractory MDS patients. Show all posts
Showing posts with label better outcomes in erythropoietin-refractory MDS patients. Show all posts
Tuesday, August 15, 2017

Combination treatment produces better outcomes in erythropoietin-refractory MDS patients, study shows

›
In continuation of my updates   lenalidomide Patients with myelodysplastic syndromes (MDS) suffer from a reduction in the number of di...